TNK Therapeutics

TNK Therapeutics is a subsidiary of Sorrento. TNK focuses on the development and commercialization of cell therapies to address unmet medical needs in the field of oncology. TNK technology reprograms immune cells to recognize and effectively kill cancer cells.